Since atorvastatin was shown to inhibit IFNγ production [29], and absence of IFNγ signaling resulted in accelerated arthritis onset [30,31], reduced production of this cytokine may be a possible mechanism underlying accelerated arthritis onset due to atorvastatin treatment. This evidence concerns the gene IFNG and Arthritis.